Patents by Inventor Leslie Magnus

Leslie Magnus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of incontinence
    Patent number: 6992109
    Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to treat incontinence.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: January 31, 2006
    Inventors: Catherine A. Segal, Leslie Magnus
  • Analgesic compositions comprising anti-epileptic compounds and methods of using same
    Patent number: 6942876
    Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions comprising same. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain alleviating properties in these novel combinations results in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these novel combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect. The present invention is also directed to methods of using effective amounts of the novel pharmaceutical compositions to treat pain in mammals.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: September 13, 2005
    Assignee: Warner-Lambert Company
    Inventors: Leslie Magnus-Miller, Douglas A. Saltel
  • Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
    Publication number: 20040002543
    Abstract: This invention is composition and method for treating sinus headache or sinus pains including analogs of glutamic acid and gamma-aminobutyric acid in combination with a decongestant.
    Type: Application
    Filed: June 30, 2003
    Publication date: January 1, 2004
    Inventors: Leslie Magnus, Catherine Segal
  • GABA analogs and an antiviral agent to treat shingles
    Publication number: 20030203921
    Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid in combination with an anti-viral agent to treat shingles.
    Type: Application
    Filed: April 2, 2003
    Publication date: October 30, 2003
    Inventors: Leslie Magnus, Catherine Segal
  • Analgesic compositions comprising anti-epileptic compounds and methods of using same
    Publication number: 20030176505
    Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions comprising same. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain alleviating properties in these novel combinations results in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these novel combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect. The present invention is also directed to methods of using effective amounts of the novel pharmaceutical compositions to treat pain in mammals.
    Type: Application
    Filed: April 4, 2003
    Publication date: September 18, 2003
    Inventors: Leslie Magnus, Douglas A. Saltel
  • Analgesic compositions comprising anti-epileptic compounds and methods of using same
    Patent number: 6593368
    Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, N-methyl-D aspartate (NMDA) receptor antagonists and non-steroidal anti-inflammatory drugs (NSAIDS) and pharmaceutical compositions comprising same.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: July 15, 2003
    Assignee: Warner-Lambert Company
    Inventors: Leslie Magnus-Miller, Douglas A. Saltel
  • Analgesic compositions comprising anti-epileptic compounds and methods of using same
    Publication number: 20030065028
    Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions comprising same. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain alleviating properties in these novel combinations results in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these novel combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect. The present invention is also directed to methods of using effective amounts of the novel pharmaceutical compositions to treat pain in mammals.
    Type: Application
    Filed: February 13, 2002
    Publication date: April 3, 2003
    Inventors: Leslie Magnus-Miller, Douglas A. Saltel
  • Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
    Publication number: 20030045500
    Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid in combination with an anti-viral agent to treat shingles.
    Type: Application
    Filed: August 6, 2002
    Publication date: March 6, 2003
    Inventors: Leslie Magnus, Catherine Segal
  • ANALGESIC COMPOSITIONS COMPRISING ANTI-EPILEPTIC COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20020115705
    Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions comprising same. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain alleviating properties in these novel combinations results in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these novel combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect.
    Type: Application
    Filed: January 18, 2000
    Publication date: August 22, 2002
    Inventors: LESLIE MAGNUS-MILLER, DOUGLAS A. SALTEL
  • Method for the treatment of insomnia
    Publication number: 20020004528
    Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to treat insomnia.
    Type: Application
    Filed: August 3, 2001
    Publication date: January 10, 2002
    Inventors: Leslie Magnus, Catherine A. Segal
  • Compositions comprising GABA analogs and caffeine
    Patent number: 6326374
    Abstract: Compositions that comprise a GABA analog, such as gabapentin or pregabalin in combination with caffeine are disclosed. The compositions are used to treat pain in mammals.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: December 4, 2001
    Assignee: Warner-Lambert Company
    Inventors: Leslie Magnus, Catherine A. Segal
  • Use of Gaba-analogues for treating insomnia
    Patent number: 6306910
    Abstract: The instant invention is a method of using analogs of glutamic acid and gamma-aminobutyric acid to treat insomnia.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: October 23, 2001
    Assignee: Warner-Lambert Company
    Inventors: Leslie Magnus, Catherine A. Segal